Peripheral artery disease

Last updated: November 01, 2022

Peripheral artery disease

MD2_HDF_II

MD2_HDF_II

Antituberculosis medications
Cardiac work
Pressure-volume loops
Blood pressure, blood flow, and resistance
Pressures in the cardiovascular system
Laminar flow and Reynolds number
Measuring cardiac output (Fick principle)
Anatomy clinical correlates: Heart
Tricuspid valve disease
Pulmonary valve disease
Mitral valve disease
Aortic valve disease
Cardiomyopathies: Pathology review
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Cardiac conduction system
Cardiac conduction velocity
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG cardiac infarction and ischemia
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart failure: Pathology review
Cor pulmonale
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Development of the cardiovascular system
Heart failure: Clinical
Adrenergic antagonists: Beta blockers
Loop diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Heart failure
Fetal circulation
Persistent truncus arteriosus
Transposition of the great vessels
Tetralogy of Fallot
Patent ductus arteriosus
Ventricular septal defect
Coarctation of the aorta
Atrial septal defect
Cardiac muscle histology
Hypertension: Pathology review
Hypertension
Thiazide and thiazide-like diuretics
Calcium channel blockers
Angina pectoris
Myocardial infarction
Peripheral artery disease
Atherosclerosis and arteriosclerosis: Pathology review
Aortic dissections and aneurysms: Pathology review
Vasculitis: Pathology review
Kawasaki disease
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Reading a chest X-ray
The role of the kidney in acid-base balance
Acid-base map and compensatory mechanisms
Acid-base disturbances: Pathology review
Respiratory acidosis
Respiratory alkalosis
Metabolic acidosis
Metabolic alkalosis
Plasma anion gap
Obstructive lung diseases: Pathology review
Chronic obstructive pulmonary disease (COPD): Clinical
Asthma: Clinical
Alpha 1-antitrypsin deficiency
Bronchiectasis
Chronic bronchitis
Cystic fibrosis
Emphysema
Restrictive lung diseases
Idiopathic pulmonary fibrosis
Sarcoidosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Pulmonary hypertension
Pulmonary edema
Tuberculosis: Pathology review
Pneumonia: Clinical
Chlamydia pneumoniae
Klebsiella pneumoniae
Mycoplasma pneumoniae
Streptococcus pneumoniae
Upper respiratory tract infection
Bacterial epiglottitis
Respiratory syncytial virus
Influenza virus
Mesothelioma
Bronchodilators: Leukotriene antagonists and methylxanthines
Bronchodilators: Beta 2-agonists and muscarinic antagonists

Flashcards

Peripheral artery disease

0 of 9 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 2 complete

A 75-year-old man comes to the clinic with persistent leg pain with exertion. Three months ago, the patient was found to have an ankle-brachial index of 0.6, and he was started on atorvastatin, chlorthalidone, and aspirin. Since then, the patient has successfully quit smoking and has participated in a supervised exercise therapy program where he has achieved a 10 lb (4.5 kg) weight loss. The pain, characterized by aching in the right thigh and buttock after walking more than 3 blocks, has not improved. The patient’s temperature is 37.0°C (98.6°F), pulse is 80/min and regular, respirations are 20/min, blood pressure is 130/75 mmHg, and BMI is 32 kg/m2. Pulses in the right femoral artery are diminished compared to the left. The patient is subsequently prescribed a medication that works via phosphodiesterase inhibition. Which of the following is the most likely medication used to treat this patient’s condition?

Transcript

Watch video only

Vascular refers to the blood vessels, and peripheral means the outer limits or edge of something, which in peripheral vascular disease refers to any vessels that aren’t supplying the heart or the brain, like ones in the legs, arms, or other organs. Peripheral vascular disease happens when one of these arteries becomes narrowed, which reduces blood flow; this often affects the limbs.

Peripheral vascular disease, or PVD, usually involves the arteries, so sometimes it’s also referred to as peripheral artery disease or PAD. PVD is usually caused by a blockage, called organic PVD, that is most commonly created by atherosclerosis. Atherosclerosis is a buildup of lipids and fibrous material just under the inner lining of the blood vessel, called the tunica intima. When plaque builds up, it narrows the artery, which reduces perfusion to whatever tissue it tends to supply; this buildup usually happens over the course of many years. However, the vessel could be blocked by an embolus, which can happen suddenly if a blood clot from some upstream artery lodges in a peripheral artery; this clot would obviously stop blood flow from getting to the tissue the vessel supplies.

Besides organic PVDs, there are also functional PVDs. With functional PVDs, blood vessels stop blood flow by changing diameter, such as with vasospasms, where the vessel constricts and blood flow is reduced. This type of PVD is usually short term, and can come and go.

The arteries supplying the legs are the most commonly affected vessels in peripheral vascular disease. When less blood gets to the muscle tissue in the legs, the tissue receives less oxygen and becomes ischemic. Ischemic cells release adenosine, a type of signaling molecule, which is thought to affect nerves in these areas; this is felt as pain. This pain in the legs is often referred to as claudication. Sometimes, even though blood flow is narrowed with PVD, when a person is at rest, there’s enough of blood to meet the tissue’s demands; thus, people are often asymptomatic during rest.

However, if the person is walking or exercising, then the leg muscles start to work harder and demand more oxygen; demand becomes greater than what’s supplied, which causes the claudication, or pain. The location of the pain is a clue to which artery is involved. If it’s in the hips and the buttocks, think of lower aorta or iliac. If it’s the thigh, think of the iliac or common femoral artery. For the upper 2/3 of the calf, think of the superficial femoral artery; for the lower ⅓ of the calf, think of the popliteal artery. Finally, for the foot, think of the tibial or peroneal artery.

Key Takeaways

Peripheral vascular disease or PVD refers to the narrowing of the arteries other than those which supply the heart and the brain. It most commonly affects the legs, but other arteries may also be involved. PVD can be organic, where the narrowing is caused by a blockage, or functional, where the blood vessel is constricted.

PVD causes a reduction in blood flow to the tissue supplied by the artery, resulting in tissue ischemia, gangrene, and necrosis. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Treatment involves lifestyle changes, medication to reduce clotting, or rarely surgery.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Peripheral vascular disease: diagnosis and treatment" Am Fam Physician (2006)
  5. "Peripheral vascular disease assessment in the lower limb: a review of current and emerging non-invasive diagnostic methods" BioMedical Engineering OnLine (2018)
  6. "Peripheral Vascular Disease" Circulation (2000)